Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
The report details the trend, potential and market size of Neurosyphilis market, and analyzes the current situation and prospects of the market from both qualitative and quantitative aspects, which can be roughly divided into three parts.
The first part (Chapter1-7) mainly covers the qualitative analysis of Neurosyphilismarket, defines the market attractiveness level of Neurosyphilis market through Porter's Five Forces Analysis, and summarizes the different factors in the overall environment through PEST analysis. Understand the distribution of industrial chain value in each link of industrial chain through the analysis of industrial chain structure. Thus estimate the market space of each link.
The second part (Chapter8-12), based on the segmentation of Neurosyphilis industry, describes the types of Neurosyphilis market, the applications of major players and the market size, and deeply analyzes the current situation of the global Neurosyphilis market and the development prospects and opportunities of Neurosyphilis industry.
The third part (Chapter14-15) includes the market positions of the major players and information on the market participants, which will help you gain a comprehensive understanding of the current competitive situation and potential growth opportunities in the market.
As COVID-19 continues to impact the global economy in 2022, the report also considers the short - and long-term impacts of COVID-19 on the global Neurosyphilis market in Chapter 13.
By Player:
GlaxoSmithKline
Bayer
Sanofi
Pfizer
Eli Lilly and Company
Novartis
Abbott
By Type:
Asymptomatic Neurosyphilis
Meningeal Neurosyphilis
Meningovascular Neurosyphilis
General Paresis
Tabes Dorsalis
By End-User:
Hospital And Clinics
Medical Research Centers
Academic Institutes
By Geography:
-
United States
-
Europe
-
China
-
Japan
-
India
-
South Korea
TABLE OF CONTENT
1 Introduction
-
1.1 Market Definition
-
1.2 Market Segment Analysis
-
1.3 Market Size 2022
-
1.4 Neurosyphilis Market Outlook: Forecast for 2022 - 2028
-
1.5 Pricing Analysis
2 Executive Summary
3 Neurosyphilis Market Lineage Outlook
-
3.1 Parent Market Outlook
-
3.2 Related/Ancillary Market Outlook
-
3.3 Penetration & Growth Prospect Mapping, 2022
4 Market Analysis Tools: Porter's Five Forces
-
4.1 Supplier Power
-
4.2 Buyer Power
-
4.3 Substitution Threat
-
4.4 Threat of New Entrants
-
4.5 Competitive Rivalry
5 Neurosyphilis Industry Analysis - PEST (Political & Legal, Economic, Social, and Technological)
-
5.1 Political/Legal Landscape
-
5.2 Economic Landscape
-
5.3 Social Landscape
-
5.4 Technology Landscape
6 Neurosyphilis Market - Value Chain Analysis
-
6.1 Industry's Value Chain Analysis
-
6.2 Product Life Cycle
-
6.3 User Perspective Analysis
7 Region and Country-wise Neurosyphilis Market Analysis and Outlook to 2022
-
7.1 Global Neurosyphilis Consumption (2017-2022)
-
7.2 United States Neurosyphilis Consumption (2017-2022)
-
7.3 Europe Neurosyphilis Consumption (2017-2022)
-
7.4 China Neurosyphilis Consumption (2017-2022)
-
7.5 Japan Neurosyphilis Consumption (2017-2022)
-
7.6 India Neurosyphilis Consumption (2017-2022)
-
7.7 South Korea Neurosyphilis Consumption (2017-2022)
8 Region and Country-wise Neurosyphilis Market Analysis and Outlook to 2028
-
8.1 Global Neurosyphilis Consumption Forecast (2022-2028)
-
8.2 United States Neurosyphilis Consumption Forecast (2022-2028)
-
8.3 Europe Neurosyphilis Consumption Forecast (2022-2028)
-
8.4 China Neurosyphilis Consumption Forecast (2022-2028)
-
8.5 Japan Neurosyphilis Consumption Forecast (2022-2028)
-
8.6 India Neurosyphilis Consumption Forecast (2022-2028)
-
8.7 South Korea Neurosyphilis Consumption Forecast (2022-2028)
9 Global Neurosyphilis Market Outlook by Types and Applications to 2022
-
9.1 Global Neurosyphilis Consumption and Growth Rate by Type (2017-2022)
-
9.1.1 Global Asymptomatic Neurosyphilis Consumption and Growth Rate (2017-2022)
-
9.1.2 Global Meningeal Neurosyphilis Consumption and Growth Rate (2017-2022)
-
9.1.3 Global Meningovascular Neurosyphilis Consumption and Growth Rate (2017-2022)
-
9.1.4 Global General Paresis Consumption and Growth Rate (2017-2022)
-
9.1.5 Global Tabes Dorsalis Consumption and Growth Rate (2017-2022)
-
9.2 Global Neurosyphilis Consumption and Growth Rate by Application (2017-2022)
-
9.2.1 Global Hospital And Clinics Consumption and Growth Rate (2017-2022)
-
9.2.2 Global Medical Research Centers Consumption and Growth Rate (2017-2022)
-
9.2.3 Global Academic Institutes Consumption and Growth Rate (2017-2022)
10 Global Neurosyphilis Market Outlook by Types and Applications to 2028
-
10.1 Global Neurosyphilis Consumption Forecast and Growth Rate by Type (2022-2028)
-
10.1.1 Global Asymptomatic Neurosyphilis Consumption Forecast and Growth Rate (2022-2028)
-
10.1.2 Global Meningeal Neurosyphilis Consumption Forecast and Growth Rate (2022-2028)
-
10.1.3 Global Meningovascular Neurosyphilis Consumption Forecast and Growth Rate (2022-2028)
-
10.1.4 Global General Paresis Consumption Forecast and Growth Rate (2022-2028)
-
10.1.5 Global Tabes Dorsalis Consumption Forecast and Growth Rate (2022-2028)
-
10.2 Global Neurosyphilis Consumption Forecast and Growth Rate by Application (2022-2028)
-
10.2.1 Global Hospital And Clinics Consumption Forecast and Growth Rate (2022-2028)
-
10.2.2 Global Medical Research Centers Consumption Forecast and Growth Rate (2022-2028)
-
10.2.3 Global Academic Institutes Consumption Forecast and Growth Rate (2022-2028)
11 Global Neurosyphilis Import and Export Analysis (Top 5 Countries)
-
11.1 Global Neurosyphilis Import by Region (Top 5 Countries) (2017-2028)
-
11.2 Global Neurosyphilis Export by Region (Top 5 Countries) (2017-2028)
12 Coronavirus Disease (COVID-19) Impact
-
12.1 Industry Impact Analysis
-
12.2 Neurosyphilis Market Outlook to 2028 - COVID-19 Affected Forecasts
13 Competition Matrix
-
13.1 Target Markets
-
13.2 Comprehensive Analysis of Products in Competitive Markets
14 Global Neurosyphilis Market Competitive Analysis
-
14.1 GlaxoSmithKline
-
14.1.1 GlaxoSmithKline Company Details
-
14.1.2 GlaxoSmithKline Neurosyphilis Sales, Price, Value and Gross Profit (2017-2022)
-
14.1.3 GlaxoSmithKline Neurosyphilis Product and Service
-
14.2 Bayer
-
14.2.1 Bayer Company Details
-
14.2.2 Bayer Neurosyphilis Sales, Price, Value and Gross Profit (2017-2022)
-
14.2.3 Bayer Neurosyphilis Product and Service
-
14.3 Sanofi
-
14.3.1 Sanofi Company Details
-
14.3.2 Sanofi Neurosyphilis Sales, Price, Value and Gross Profit (2017-2022)
-
14.3.3 Sanofi Neurosyphilis Product and Service
-
14.4 Pfizer
-
14.4.1 Pfizer Company Details
-
14.4.2 Pfizer Neurosyphilis Sales, Price, Value and Gross Profit (2017-2022)
-
14.4.3 Pfizer Neurosyphilis Product and Service
-
14.5 Eli Lilly and Company
-
14.5.1 Eli Lilly and Company Company Details
-
14.5.2 Eli Lilly and Company Neurosyphilis Sales, Price, Value and Gross Profit (2017-2022)
-
14.5.3 Eli Lilly and Company Neurosyphilis Product and Service
-
14.6 Novartis
-
14.6.1 Novartis Company Details
-
14.6.2 Novartis Neurosyphilis Sales, Price, Value and Gross Profit (2017-2022)
-
14.6.3 Novartis Neurosyphilis Product and Service
-
14.7 Abbott
-
14.7.1 Abbott Company Details
-
14.7.2 Abbott Neurosyphilis Sales, Price, Value and Gross Profit (2017-2022)
-
14.7.3 Abbott Neurosyphilis Product and Service
15 Appendix
TABLE OF CHARTS
-
Table Definition of Neurosyphilis
-
Figure Neurosyphilis Picture
-
Table Global Neurosyphilis Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global Neurosyphilis Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global Neurosyphilis Market: Year-over-year Growth 2022 - 2028 (%)
-
Table Parent Market Analysis
-
Figure Parent Market Price
-
Table Related/Ancillary Market Outlook Analysis
-
Table Supplier Power Analysis
-
Table Buyer Power Analysis
-
Table Substitution Threat Analysis
-
Table Threat of New Entrants Analysis
-
Table Competitive Rivalry Analysis
-
Figure Global Neurosyphilis Consumption by Country (2017-2022)
-
Figure United States Neurosyphilis Consumption and Growth Rate (2017-2022)
-
Table Europe Neurosyphilis Consumption and Growth Rate (2017-2022)
-
Figure China Neurosyphilis Consumption and Growth Rate (2017-2022)
-
Figure Japan Neurosyphilis Consumption and Growth Rate (2017-2022)
-
Figure India Neurosyphilis Consumption and Growth Rate (2017-2022)
-
Figure South Korea Neurosyphilis Consumption and Growth Rate (2017-2022)
-
Figure Global Neurosyphilis Consumption Forecast by Country (2022-2028)
-
Figure United States Neurosyphilis Consumption Forecast and Growth Rate (2022-2028)
-
Table Europe Neurosyphilis Consumption Forecast and Growth Rate (2022-2028)
-
Figure China Neurosyphilis Consumption Forecast and Growth Rate (2022-2028)
-
Figure Japan Neurosyphilis Consumption Forecast and Growth Rate (2022-2028)
-
Figure India Neurosyphilis Consumption Forecast and Growth Rate (2022-2028)
-
Figure South Korea Neurosyphilis Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Asymptomatic Neurosyphilis Consumption and Growth Rate (2017-2022)
-
Figure Global Meningeal Neurosyphilis Consumption and Growth Rate (2017-2022)
-
Figure Global Meningovascular Neurosyphilis Consumption and Growth Rate (2017-2022)
-
Figure Global General Paresis Consumption and Growth Rate (2017-2022)
-
Figure Global Tabes Dorsalis Consumption and Growth Rate (2017-2022)
-
Figure Global Hospital And Clinics Consumption and Growth Rate (2017-2022)
-
Figure Global Medical Research Centers Consumption and Growth Rate (2017-2022)
-
Figure Global Academic Institutes Consumption and Growth Rate (2017-2022)
-
Figure Global Asymptomatic Neurosyphilis Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Meningeal Neurosyphilis Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Meningovascular Neurosyphilis Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global General Paresis Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Tabes Dorsalis Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Hospital And Clinics Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Medical Research Centers Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Academic Institutes Consumption Forecast and Growth Rate (2022-2028)
-
Table Global Neurosyphilis Import by Region (Top 5 Countries) (2017-2028)
-
Table Global Neurosyphilis Export by Region (Top 5 Countries) (2017-2028)
-
Table GlaxoSmithKline (Foundation Year, Company Profile and etc.)
-
Table GlaxoSmithKline Neurosyphilis Sales, Price, Value and Gross Profit (2017-2022)
-
Table GlaxoSmithKline Neurosyphilis Product and Service
-
Table Bayer (Foundation Year, Company Profile and etc.)
-
Table Bayer Neurosyphilis Sales, Price, Value and Gross Profit (2017-2022)
-
Table Bayer Neurosyphilis Product and Service
-
Table Sanofi (Foundation Year, Company Profile and etc.)
-
Table Sanofi Neurosyphilis Sales, Price, Value and Gross Profit (2017-2022)
-
Table Sanofi Neurosyphilis Product and Service
-
Table Pfizer (Foundation Year, Company Profile and etc.)
-
Table Pfizer Neurosyphilis Sales, Price, Value and Gross Profit (2017-2022)
-
Table Pfizer Neurosyphilis Product and Service
-
Table Eli Lilly and Company (Foundation Year, Company Profile and etc.)
-
Table Eli Lilly and Company Neurosyphilis Sales, Price, Value and Gross Profit (2017-2022)
-
Table Eli Lilly and Company Neurosyphilis Product and Service
-
Table Novartis (Foundation Year, Company Profile and etc.)
-
Table Novartis Neurosyphilis Sales, Price, Value and Gross Profit (2017-2022)
-
Table Novartis Neurosyphilis Product and Service
-
Table Abbott (Foundation Year, Company Profile and etc.)
-
Table Abbott Neurosyphilis Sales, Price, Value and Gross Profit (2017-2022)
-
Table Abbott Neurosyphilis Product and Service
-
